SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-046781
Filing Date
2023-09-06
Accepted
2023-09-06 17:09:02
Documents
14
Period of Report
2023-09-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230906.htm   iXBRL 8-K 62023
2 EX-99.1 gls-ex99_1.htm EX-99.1 538
3 PDF COURTESY COPY gls-ex99_1.pdf EX-99.1 2106567
  Complete submission text file 0000950170-23-046781.txt   3059325

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230906_pre.xml EX-101.PRE 10193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230906_lab.xml EX-101.LAB 12409
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230906.xsd EX-101.SCH 2465
8 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230906_htm.xml XML 4356
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 231240041
SIC: 2834 Pharmaceutical Preparations